Jynneos is a vaccine approved by the FDA for prevention of smallpox and monkeypox. It is an attenuated virus vaccine that is given to people who are at risk of exposure to these diseases, such as laboratory workers, military personnel, and healthcare workers.
The Jynneos vaccine information sheet (VIS) is an important document that provides information about the vaccine, including its benefits and potential risks. It is important for people who are considering getting vaccinated with Jynneos to understand what is contained in the VIS.
One of the key pieces of information in the Jynneos VIS is the list of contraindications. These are medical conditions or situations where the vaccine should not be given, as they may increase the risk of adverse reactions. Some of the contraindications for Jynneos include a weakened immune system, pregnancy, and allergy to any of the vaccine components.
The VIS also provides information on common side effects of Jynneos, which may include fever, headache, and fatigue. These side effects typically occur within a few days of the vaccination and are generally mild and short-lived.
In addition to these standard components, the Jynneos VIS also contains information on the manufacturing process and composition of the vaccine, as well as instructions for healthcare providers on proper administration and storage.
It is important for individuals considering vaccination with Jynneos to review the information contained in the VIS carefully and to discuss any questions or concerns with their healthcare providers. By understanding the risks and benefits of the vaccine, individuals can make informed decisions about whether or not to receive the vaccine.
In conclusion, the Jynneos vaccine information sheet is an important resource for individuals considering vaccination with this vaccine. It provides valuable information on contraindications, side effects, and administration, as well as other relevant facts about the vaccine. By reviewing this information carefully and discussing any questions or concerns with a healthcare provider, individuals can make informed decisions about whether or not to receive the Jynneos vaccine.
